Manulife Financial

MFC-T

TSE:MFC

27.61
0.36 (1.32%)
Manulife Financial Corporation is a Canadian multinational insurance company and financial services provider headquartered in Toronto, Ontario, Canada.
More at Wikipedia

Analysis and Opinions about MFC-T

Signal
Opinion
Expert
BUY
BUY
January 14, 2020
Why is this trading at $27 when it should be over $30? MFC is transitioning. Insurance is a very long-tail businesses with products that need a lot of time to pay off (insurance policies). Their wealth management business in Asia is strong. It's been a long haul for MFC, going back to the Great Recession, and have been making slow progress. They are growing their book value. If things continue, they will grow their earnings and generally improve. She's happy to hold it. They're quarterly results are becoming consistent which will drive the stock. Pays a 3.6% yield.
Show full opinionHide full opinion
Manulife Financial (MFC-T)
January 14, 2020
Why is this trading at $27 when it should be over $30? MFC is transitioning. Insurance is a very long-tail businesses with products that need a lot of time to pay off (insurance policies). Their wealth management business in Asia is strong. It's been a long haul for MFC, going back to the Great Recession, and have been making slow progress. They are growing their book value. If things continue, they will grow their earnings and generally improve. She's happy to hold it. They're quarterly results are becoming consistent which will drive the stock. Pays a 3.6% yield.
DON'T BUY
DON'T BUY
January 14, 2020
Not a quality growth company. MFC is too hard for him to figure out. He'd rather buy a Canadian or American bank like National Bank.
Show full opinionHide full opinion
Manulife Financial (MFC-T)
January 14, 2020
Not a quality growth company. MFC is too hard for him to figure out. He'd rather buy a Canadian or American bank like National Bank.
BUY
BUY
January 9, 2020

MFC vs. SLF When he values lifecos, it's on price to book, dividend yield, or price to earnings, rather than price to cash flows. Sun Life trades at a premium. His preferred lifeco is Manulife, because of a discounted valuation plus a better business overall because of its Asian business. Wealth management is also better, and getting a handle on legacy businesses.

Show full opinionHide full opinion

MFC vs. SLF When he values lifecos, it's on price to book, dividend yield, or price to earnings, rather than price to cash flows. Sun Life trades at a premium. His preferred lifeco is Manulife, because of a discounted valuation plus a better business overall because of its Asian business. Wealth management is also better, and getting a handle on legacy businesses.

TOP PICK
TOP PICK
January 8, 2020

It hit a 52 week high yesterday. There is potential for a resolution for some of their long term holdings. They are growing in Asia, where there are higher margins. It trades at a sizable valuation discount to its peers in the space. Yield 3.63% (Analysts’ price target is $30.33)

Show full opinionHide full opinion

It hit a 52 week high yesterday. There is potential for a resolution for some of their long term holdings. They are growing in Asia, where there are higher margins. It trades at a sizable valuation discount to its peers in the space. Yield 3.63% (Analysts’ price target is $30.33)

BUY
BUY
January 7, 2020
Recent break-out Jan. 23 to mid-April is the lifecos' (and banks') seasonality. The chart is setting up for a break-out as MFC approaches its highs of early-2018. Chart looks very good, and MFC will do pretty well.
Show full opinionHide full opinion
Recent break-out Jan. 23 to mid-April is the lifecos' (and banks') seasonality. The chart is setting up for a break-out as MFC approaches its highs of early-2018. Chart looks very good, and MFC will do pretty well.
TOP PICK
TOP PICK
January 7, 2020
Superb dividend at 3.73%. Earning have steadily been rising and yet the price hasn't budged much in past year. Its rising fair market value is a good sign and it may go higher. (Analysts’ price target is $30.33)
Show full opinionHide full opinion
Superb dividend at 3.73%. Earning have steadily been rising and yet the price hasn't budged much in past year. Its rising fair market value is a good sign and it may go higher. (Analysts’ price target is $30.33)
PAST TOP PICK
PAST TOP PICK
January 6, 2020
(A Top Pick Jan 15/19, Up 33%) You never know when is going to have a good year. They had been increasing their dividend on flat performance so the yield going into last year was well over 4%. He thinks the new management team is doing the right things. It is still discounted relative to its peers. We are unlikely to see another year of 33%.
Show full opinionHide full opinion
(A Top Pick Jan 15/19, Up 33%) You never know when is going to have a good year. They had been increasing their dividend on flat performance so the yield going into last year was well over 4%. He thinks the new management team is doing the right things. It is still discounted relative to its peers. We are unlikely to see another year of 33%.
BUY
BUY
January 2, 2020
It is a good company and he thinks it is going higher. They seem to be on a bit of a roll. You could take some profits if you wanted to.
Show full opinionHide full opinion
It is a good company and he thinks it is going higher. They seem to be on a bit of a roll. You could take some profits if you wanted to.
BUY
BUY
December 31, 2019
MFC vs. CM They were late to get US exposure, which hurt them. Also, there's negativity towards CM's mortgage book. TD and RY remain the top Canadian banks, not CM. TD & RY are investing in tech, the future, which is smart. MFC: The lifecos have done well diversifying into asset management and into Asia. But with low interest rates, pricing insurance gets tougher and limits growth. You own lifecos for Asia and wealth management. Not CM, but buy TD and Royal.
Show full opinionHide full opinion
Manulife Financial (MFC-T)
December 31, 2019
MFC vs. CM They were late to get US exposure, which hurt them. Also, there's negativity towards CM's mortgage book. TD and RY remain the top Canadian banks, not CM. TD & RY are investing in tech, the future, which is smart. MFC: The lifecos have done well diversifying into asset management and into Asia. But with low interest rates, pricing insurance gets tougher and limits growth. You own lifecos for Asia and wealth management. Not CM, but buy TD and Royal.
BUY
BUY
December 23, 2019
We had a nice little bottom from August. It is at resistance. $26 has been a resistance since early 2018. As long as the stock market goes higher, it will be good for MFC-T. He likes the insurers over the financials. He only like US financials better that Canadian insurance companies. See his Top Picks today. (Analysts’ price target is $30.00)
Show full opinionHide full opinion
Manulife Financial (MFC-T)
December 23, 2019
We had a nice little bottom from August. It is at resistance. $26 has been a resistance since early 2018. As long as the stock market goes higher, it will be good for MFC-T. He likes the insurers over the financials. He only like US financials better that Canadian insurance companies. See his Top Picks today. (Analysts’ price target is $30.00)
COMMENT
COMMENT
December 18, 2019

Canada has four major life insurance companies. Since the financial crisis, Sun Life aas done the best. He does not see much change at Manulife so would prefer Sun Life.

Show full opinionHide full opinion
Manulife Financial (MFC-T)
December 18, 2019

Canada has four major life insurance companies. Since the financial crisis, Sun Life aas done the best. He does not see much change at Manulife so would prefer Sun Life.

COMMENT
COMMENT
December 10, 2019
Enter now for the long term? When interest rates are down, they hurt lifecos. But MFC beat their numbers handily last quarter. Asian operations are strong. He's neutral on insurance companies, because rates are so low. However, their valuation is cheap--but also cheap for so long. In 2020, he'll look at the lifecos again. Problem with lifecos is they're like a black box--you don't know what's inside sometimes.
Show full opinionHide full opinion
Manulife Financial (MFC-T)
December 10, 2019
Enter now for the long term? When interest rates are down, they hurt lifecos. But MFC beat their numbers handily last quarter. Asian operations are strong. He's neutral on insurance companies, because rates are so low. However, their valuation is cheap--but also cheap for so long. In 2020, he'll look at the lifecos again. Problem with lifecos is they're like a black box--you don't know what's inside sometimes.
HOLD
HOLD
December 9, 2019
The history of what happened 10 years ago weighs on the minds of institutional investors. It is frustrating. At some point in time they should figure out a way to recognize the value.
Show full opinionHide full opinion
Manulife Financial (MFC-T)
December 9, 2019
The history of what happened 10 years ago weighs on the minds of institutional investors. It is frustrating. At some point in time they should figure out a way to recognize the value.
BUY
BUY
December 9, 2019

MFC vs. SLF They're both good and relatively safe. They both have asset management businesses. Earnings growth will be 7-11% in 2020, which is far higher than the 1-3% for the banks. Also, they trade at single-digit multiples, cheap. According to book value, SLF is far more expensive, so he prefers MFC. MFC has more upside than SLF, but you're splitting hairs with these two.

Show full opinionHide full opinion
Manulife Financial (MFC-T)
December 9, 2019

MFC vs. SLF They're both good and relatively safe. They both have asset management businesses. Earnings growth will be 7-11% in 2020, which is far higher than the 1-3% for the banks. Also, they trade at single-digit multiples, cheap. According to book value, SLF is far more expensive, so he prefers MFC. MFC has more upside than SLF, but you're splitting hairs with these two.

TOP PICK
TOP PICK
December 4, 2019
Pays a nice dividend. FMV is way above the current price, 167% higher. Good Balance sheet. Book value is in an uptrend. PB is very cheap. $26.50 is resistance, so watch that, but it has busted past that before. If so, it should reach $31-32. Are expanding international. Growing earnings. What's not to like. (Analysts’ price target is $29.91)
Show full opinionHide full opinion
Manulife Financial (MFC-T)
December 4, 2019
Pays a nice dividend. FMV is way above the current price, 167% higher. Good Balance sheet. Book value is in an uptrend. PB is very cheap. $26.50 is resistance, so watch that, but it has busted past that before. If so, it should reach $31-32. Are expanding international. Growing earnings. What's not to like. (Analysts’ price target is $29.91)
Showing 1 to 15 of 1,953 entries